Showing results (251-260 of 3,469) with videos related to
Sort By:
Pageof 347
Clinical Pharmacokinetics|May 6, 2005
Lack of pharmacokinetic interactions between steady-state zonisamide and valproic acid in patients with epilepsyIsabelle Ragueneau-Majlessi, Rene H Levy, Martin Brodie, et al.Clinical Pharmacokinetics|June 29, 2006
Cerebrospinal fluid distribution of ketoprofen after intravenous administration in young childrenAnne Mannila, Hannu Kokki, Marja Heikkinen, et al.Clinical Pharmacokinetics|June 22, 2005
Paradoxical role of cytochrome P450 3A in the bioactivation and clinical effects of levo-alpha-acetylmethadol: importance of clinical investigations to validate in vitro drug metabolism studiesEvan D Kharasch, Dale Whittington, Christine Hoffer, et al.Clinical Pharmacokinetics|June 22, 2005
Modafinil influences the pharmacokinetics of intravenous cocaine in healthy cocaine-dependent volunteersJennifer L Donovan, C Lindsay DeVane, Robert J Malcolm, et al.Clinical Pharmacokinetics|December 17, 2022
Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338)Olivier Petricoul, Arman Nazarian, Uwe Schuehly, et al.Clinical Pharmacokinetics|December 5, 2022
Pilot Pharmacokinetic Study in Healthy Adults Using Intravascular Microdialysis Catheters Modified for Use in Paediatric Patients to Assess Vancomycin Blood LevelsValentin Al Jalali, Martin Bauer, Michael Wölfl-Duchek, et al.Clinical Pharmacokinetics|June 28, 2022
Population Pharmacokinetics of Asciminib in Tyrosine Kinase Inhibitor-Treated Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic and Acute PhasesYing Fei Li, Francois Pierre Combes, Matthias Hoch, et al.Clinical Pharmacokinetics|June 28, 2022
Clinical Pharmacokinetics and Pharmacodynamics of CefepimeGwendolyn M Pais, Jack Chang, Erin F Barreto, et al.Clinical Pharmacokinetics|December 26, 2022
Upadacitinib Population Pharmacokinetics and Exposure-Response Relationships in Ulcerative Colitis PatientsAna Victoria Ponce-Bobadilla, Sven Stodtmann, Doerthe Eckert, et al.Clinical Pharmacokinetics|June 23, 2021
A Population Pharmacokinetic Model of Macitentan and Its Active Metabolite Aprocitentan in Healthy Volunteers and Patients with Pulmonary Arterial HypertensionRoberta Bartolucci, Anne-Gaëlle Dosne, Dénes Csonka, et al.Pageof 347